INCREASED PLASMA GLUCAGON LEVELS FOLLOWING TREATMENT WITH PHENFORMIN (DBI)

被引:0
|
作者
HARDING, HR
GAUVIN, BR
POTTS, GO
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:328 / 328
页数:1
相关论文
共 50 条
  • [1] PLASMA GLUCAGON SUPPRESSION BY PHENFORMIN IN MAN
    BOHANNON, NV
    LORENZI, M
    GERICH, JE
    KARAM, JH
    DIABETES, 1975, 24 : 428 - 428
  • [2] PLASMA GLUCAGON SUPPRESSION BY PHENFORMIN IN MAN
    BOHANNON, NV
    KARAM, JH
    LORENZI, M
    GERICH, JE
    MATIN, SB
    FORSHAM, PH
    DIABETOLOGIA, 1977, 13 (05) : 503 - 508
  • [3] PLASMA GLUCAGON LEVELS AFTER TOLBUTAMIDE OR PHENFORMIN IN INSULIN-DEPENDENT DIABETICS
    BOHANNON, N
    KARAM, J
    LORENZI, M
    GERICH, J
    FORSHAM, P
    CLINICAL RESEARCH, 1976, 24 (02): : A154 - A154
  • [4] PLASMA PHENFORMIN LEVELS FOLLOWING A STANDARD THERAPEUTIC DOSE IN DIABETICS
    CATELLIER, C
    FRASER, E
    AYOTTEFERRON, L
    SAVOIE, JY
    DIABETES, 1976, 25 : 357 - 357
  • [5] PLASMA CATECHOLAMINE LEVELS IN MAN FOLLOWING INJECTION OF SUBCUTANEOUS GLUCAGON
    GOODWIN, PM
    CAPILDEO, R
    HARROP, JS
    MARKS, V
    ROSE, FC
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1976, 50 (02): : P19 - P20
  • [6] EFFECT OF PHENFORMIN ON PLASMA GLUCAGON-LIKE IMMUNOREACTIVITY (GLI) CONCENTRATIONS
    LANGSLOW, DR
    BUCHANAN, KD
    FREEMAN, BM
    DIABETOLOGIA, 1974, 10 (04) : 375 - 375
  • [8] INCREASED LEVELS OF PLASMA-INSULIN AND 11 11-HYDROXYCORTICOSTEROIDS INDUCED BY SUCROSE, AND THEIR REDUCTION BY PHENFORMIN
    YUDKIN, J
    SZANTO, S
    HORMONE AND METABOLIC RESEARCH, 1972, 4 (06) : 417 - 420
  • [9] PLASMA GLUCAGON LEVELS IN ACROMEGALY
    TAMBURRANO, G
    FALLUCA, F
    DIMARIO, U
    TAMBURRANO, S
    MENZINGER, G
    JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE, 1976, 20 (03): : 115 - 116
  • [10] Increased gene expression and plasma levels of glucose dependent insulinotropic polypeptide following clozapine treatment
    Singh, AN
    Castellano, JM
    Sondhi, S
    Thomas, N
    Dyck, BA
    Skoblenick, KJ
    Mishra, RK
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A39 - A39